Inovotion is a corporate sponsor of this conference focusing on Models & Tools to decrease the rate of clinical failures in oncology and immuno-oncology.

Jean Viallet PhD, Inovotion’s CEO/CSO will make a 15-minute pitch entitled Unique in vivo Tests for Cancer Drug Discovery: Early Identification of High Value Leads to highlight our approach focused on developing new therapies and technologies allowing preclinical and translational research to maximize their chances of success in developing new cancer therapies.

Inovotion will to continue to build notoriety in the US during this event which attracts 1000+ industrial participants.